These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1507762)

  • 21. Mass screening for colorectal cancer: compliance in Almopea Region.
    Chrissidis T; Saliangas K; Economou A; Nikoloudis N; Andreadis E; Prodromou K; Georgakis K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s193-5. PubMed ID: 15655620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for colorectal cancer.
    Ross CC
    Am Fam Physician; 1988 Dec; 38(6):105-14. PubMed ID: 3057836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions.
    Lobchuk MM; Bapuji SB; McClement SE; Sisler JJ; Katz A; Martens P; Turner D; Clouston K
    Cancer Epidemiol; 2012 Jun; 36(3):e190-9. PubMed ID: 22310235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Screening colonoscopy for early detection of intestinal cancer].
    Mader U
    Dtsch Med Wochenschr; 2003 Mar; 128(12):596. PubMed ID: 12685432
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of fecal occult blood and colorectal cancer].
    Herrerías Gutiérrez JM; Caunedo Alvarez JM; Herrerías Esteban JM
    Rev Esp Enferm Dig; 1999 May; 91(5):331-4. PubMed ID: 10362874
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for colorectal cancer in Europe.
    Keighley MR
    Scand J Gastroenterol; 2004 Sep; 39(9):805-6. PubMed ID: 15513376
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of immunofecal occult blood test on colorectal cancer screening].
    Yang HY; Ge ZZ; Dai J; Li XB; Gao YJ
    Zhonghua Nei Ke Za Zhi; 2008 Aug; 47(8):642-5. PubMed ID: 19080296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of colorectal cancer stage among HMO members targeted for screening.
    Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
    Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early detection of colorectal carcinoma. Are you aware of the screening intervals?].
    Pox C; Schmiegel W
    MMW Fortschr Med; 1999 Sep; 141(36):45-6. PubMed ID: 10904599
    [No Abstract]   [Full Text] [Related]  

  • 31. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
    Saito H
    J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass screening for colorectal cancer in Japan.
    Hisamichi S; Fukao A; Fujii Y; Tsuji I; Komatsu S; Inawashiro H; Tsubono Y
    Cancer Detect Prev; 1991; 15(5):351-6. PubMed ID: 1751945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is bowel cancer screening important for Maori?
    Sarfati D; Hill S; Blakely T; Robson B
    N Z Med J; 2010 Aug; 123(1320):9-12. PubMed ID: 20720598
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening for colorectal cancer with Hemoccult-II in the average risk population.
    Kronborg O
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S44-8. PubMed ID: 9762237
    [No Abstract]   [Full Text] [Related]  

  • 35. [Faecal occult blood test and mass screening for colorectal cancer].
    Hiwatashi N; Shimada T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
    [No Abstract]   [Full Text] [Related]  

  • 36. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing colorectal cancer screening in rural southern Taiwan.
    Lin YH; Kao CC
    Cancer Nurs; 2013; 36(4):284-91. PubMed ID: 22964866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer screening.
    Cheung WY
    CMAJ; 2008 Jan; 178(2):189; author reply 189. PubMed ID: 18195297
    [No Abstract]   [Full Text] [Related]  

  • 39. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing.
    Halloran SP; Launoy G; Zappa M;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE65-87. PubMed ID: 23012123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.